General Information of Disease (ID: DISGMI3Q)

Disease Name Autosomal dominant hyperinsulinism due to SUR1 deficiency
Synonyms autosomal dominant hyperinsulinemic hypoglycemia due to SUR1 deficiency
Definition
Autosomal dominant hyperinsulinism due to SUR1 deficiency is a form of diazoxide-sensitive diffuse hyperinsulinism (DHI), characterized by hypoglycemic epiosodes that are usually mild, escaping detection during infancy and usually a good clinical response to diazoxide. Autosomal dominant hyperinsulinism due to SUR1 deficiency usually has a milder phenotype when compared to that resulting from recessive K-ATP mutations (recessive forms of Diazoxide-resistant hyperinsulinism).
Disease Hierarchy
DISOEYSO: Diazoxide-sensitive diffuse hyperinsulinism
DISGMI3Q: Autosomal dominant hyperinsulinism due to SUR1 deficiency
Disease Identifiers
MONDO ID
MONDO_0017184
UMLS CUI
C4274080
MedGen ID
900764
Orphanet ID
276575
SNOMED CT ID
717046003

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ABCC8 TTP835K moderate GermlineCausalMutation [1]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
ABCC8 DTI58LU Supportive Autosomal dominant [2]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ABCC8 OTCWQ54I Supportive Autosomal dominant [2]
------------------------------------------------------------------------------------

References

1 Molecular mechanisms of congenital hyperinsulinism.J Mol Endocrinol. 2015 Apr;54(2):R119-29. doi: 10.1530/JME-15-0016. Epub 2015 Mar 2.
2 Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest. 2000 Oct;106(7):897-906. doi: 10.1172/JCI9804.